1. 1. Hasserjian RP, Orazi A, Brunning RD, et al. Myelodysplastic syndromes: Overview. In: Ed. By Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. Lyon, France: IARC; 2016: 98-106.
2. 2. 日本における造血細胞移植. 2019年度 全国調査報告書. 日本造血細胞移植データセンター/日本造血細胞移植学会
3. 3. Sanz M, Vallespi T, Hamblin T, et al. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes. Blood. 1997; 89: 2079-2088.
4. 4. Greenberg PL, Tuechler H, Schanz J, et al. Revised International Prognostic Scoring System for Myelodysplastic Syndromes. Blood. 2012; 120: 2454-2465.
5. 5. 造血器腫瘍診療ガイドライン. 2020年増補版. 日本血液学会編.